Tradestie Institutional Equity Comparison Engine

FRMM vs QNRX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

QNRX Overall Edge

QNRX Captures Institutional Edge (2โ€“1 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) driven by superior Valuation, Growth & Margin while FRMM counters with relative strength in Momentum & Technical. Fundamentally, FRMM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus QNRX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, FRMM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner QNRX
FRMM N/M vs QNRX N/M Fwd P/E
Growth & Margin Winner QNRX
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner FRMM
1Y -44.5% vs -82.0% ยท 52W Pos 3% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
FRMM US Equity
FRMM
Institutional Equity
$1.92
-4.48% 1D
Market Cap N/A
1M Return -42.34%
1Y Return -44.51%
Forward P/E N/M
Unified AI Score
42.5 / 100 HOLD
Tech 35.0 Fund 44.0 Flow 50.0 Mom 55.0
QNRX NASDAQ
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Pharmaceutical Preparations
$3.28
-2.35% 1D
Market Cap $16.1M
1M Return -18.2%
1Y Return -81.96%
Forward P/E N/M
Unified AI Score
46.1 / 100 HOLD
Tech 38.0 Fund 47.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FRMM -44.51% QNRX -81.96% Spread: +16.99 pp (FRMM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
FRMM TTM Op. Margin: N/A QNRX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FRMM vs QNRX. Trailing 12-month operating profitability (FRMM N/A vs QNRX 0.0%) and valuation multiples (FRMM N/M vs QNRX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FRMM (1) vs QNRX (8)
Institutional Metric FRMM QNRX Criterion Row Winner
Market Capitalization Scale N/A $16.1M Larger Scale QNRX
Trailing P/E Ratio Valuation N/M 7.6x Lower Multiple QNRX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth QNRX
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin QNRX
Net Profit Margin Profitability N/A 0.0% Higher Margin QNRX
Return on Equity (ROE) Capital Efficiency N/A -142.6% Higher ROE QNRX
52-Week Range Position Momentum 3% ($2โ€“$7) 0% ($3โ€“$24) Stronger Trend FRMM
Beta / 30D Volatility Risk Regime 2.28ฮฒ ยท 107% Vol 1.34ฮฒ ยท 74% Vol Lower Realized Risk QNRX
Unified Institutional Score Composite Signal 42.5 / 100 (HOLD) 46.1 / 100 (HOLD) Higher Composite QNRX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FRMM vs QNRX Buy Guide
FRMM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FRMM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
QNRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live QNRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FRMM nor QNRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.